Abstract

Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide

Author(s): Zur Eyal

Issue: Jul/Aug 2012 - Volume 16, Number 4

Page(s): 288-293

Download in electronic PDF format for $75

Abstract

Eosinophilic esophagitis is a clinicopathologic disease isolated to the esophagus. It is caused by immunologic reactions to ingested and inhaled allergans. Symptoms include regurgitation, vomiting, pain, anorexia, and dysphagia. Endoscopy with biopsy is currently the only reliable diagnostic test for eosinophilic esophagitis. The disease should remit with treatments of dietary exclusion, topical corticosteroids, or both. Oral viscous budesonide is one of the promising options of topical corticosteroid to treat eosinophilic esophagitis. Since there are no commercial medicines of oral viscous budesonide, it is solely a compounded medication. This article briefly discusses the properties of the disease and covers a few compounding possibilities to oral viscous budesonide.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2012 Pg. 288-293	Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide Author(s): Zur Eyal
Jul/Aug 2004 Pg. 269-274	Current Topical Treatments in Wound Healing - Part 1 Author(s): Helmke Christopher D
Jul/Aug 2021 Pg. 323	Budesonide 0.0.25% Mucoadhesive Gel Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 376-381	Oral Viscous Sucralfate Gel for Post-procedural Treatment of Barrett's Esophagus Author(s): Zur Eyal
Jul/Aug 2017 Pg. 322-329	Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox) Author(s): Ip Kendice, Carvalho Maria, Shan Ashley, Banov Daniel
May/Jun 2015 Pg. 243	Lidocaine Hydrochloride 2% Viscous Oral Topical Solution Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 206-209	Basics of Compounding for Cold Sores or Fever Blisters Author(s): Allen Loyd V Jr
Jul/Aug 2003 Pg. 266-270	Sensitization Therapy for Warts Author(s): Kuntz Rachael
Sep/Oct 2015 Pg. 357-365	Novel Approaches to Topical Psoriasis Therapy Author(s): Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Jul/Aug 2018 Pg. 317	Budesonide 1-mg//10-mL Mucolox Oral Suspensions Author(s): Allen Loyd V Jr
May/Jun 2003 Pg. 176-178	Case Report: Topical Gel for the Treatment of a Refractory Leg Ulcer Author(s): Israel Alan
Jul/Aug 2003 Pg. 288-291	Basics of Compounding for Raynaud's Disease Author(s): Glasnapp Andrew
Sep/Oct 2024 Pg. 400	Lidocaine Hydrochloride 2% Viscous Oral Topical Solution Author(s): Allen Loyd V Jr
Nov/Dec 2024 Pg. 486	Lidocaine Hydrochloride 2% Viscous Oral Topical Solution Author(s): Allen Loyd V Jr
Jan/Feb 2004 Pg. 10-14	Women's Oral Health: Is There a Hormonal Link? Author(s): Preckshot John
May/Jun 2013 Pg. 254-261	Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline Author(s): Klemmer Anja, Krämer Irene, Kamin Wolfgang
Nov/Dec 2012 Pg. 462-469	Recurrent Aphthous Stomatitis: Topical Treatment with Minocycline and Other Evidence-based Agents Author(s): Zur Eyal
Nov/Dec 2022 Pg. 509	Curcumin 2% Topical Gel Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 232	Anhydrous Silicon Base Topical Gel Vehicle Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 366-375	Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 3 Author(s): Zur Eyal